to page content
to site navigation
The Foundation's primary site.
Global news, events, and resources.
The national learning program for entrepreneurs.
A new approach to developing the next generation of high-growth firms.
Access to university research and innovation.
The Kauffman Foundation's charter school serving Kansas City.
Encouraging the aspirations of young people.
The platform for business plan competitions.
College preparation and access for urban youth in Kansas City.
A guide to Kauffman Foundation and partner resources, for aspiring entrepreneurs.
News and announcements from the Foundation.
From our vice president of Entrepreneurship.
From our vice president of Advancing Innovation.
News from Global Entrepreneurship Week
News about this education program for entrepreneurs.
Tweets for the eMed Community at Entrepreneurship.org
News from the Kauffman Labs program.
From our business plan competition service.
Contribute to the community seeking to improve entrepreneurship and innovation measurement.
A look at entrepreneurship from the Kauffman Foundation's Thom Ruhe.
Tracks research and policies that are accelerating economic growth and changing the world.
Brings to light various policies and initiatives to advance innovation and drive economic growth.
A selection of our videos
Take our video and audio with you.
Explore many of our publications.
Join the discussion on our LinkedIn site.
Join us on Google's social service.
The Resource Center has all the info you'll need From content to user feedback, the resource center has the information you need for every level of the entrepreneurial process.
John McKew PhD, Chief, Therapeutics Development Branch, Division of Preclinical Innovation Therapeutics for Rare and Neglected Diseases (TRND) May 22, 2012, hosted by the Kauffman Foundation
John G. Melo is the Chief Executive Officer of Amyris Biotechnologies, a synthetic biology company working to reduce the cost of curing malaria and producing lower carbon, second generation bio-fuels. He was previously
president of U.S. Fuels for BP, where he led one of the world's largest petroleum marketing, logistics, and trading businesses. While in this role he successfully grew revenues from $25 billion to $34 billion and increased net cash by $1
billion. During this time his team developed one of the world's most successful ethanol blending and marketing businesses. He also worked on the development of BP's "Helios" re-branding. Prior to his eight years with BP, Mr. Melo was a
director with Ernst & Young in San Jose, California, and a management team member for several Northern California start-ups, including Computer Aided Services and Alldata Corporation. John serves on the Board of Directors for U.S. Oil,
a $1.6 billion energy company, and Cilion, a leading low-cost ethanol manufacturer. John is a member of the Economic Club of Chicago, The Chicago Club, The Chicago Council on Global Affairs, and YPO. He enjoys visiting his home country of
Azores, Portugal, as well as skiing, biking, tennis, golf, and time with his children.
Video from the Translation Medicine Alliance Forum now available
A convening of university scientist, former and current industry leaders, philanthropy, and government yielded deep-dive discussions regarding obstacles that must be immediately overcome if we are going to maintain and grow an industry that is a significant part of America’s GDP. Watch videos from the recent Translational Medicine Alliance Forum (TMAF) to understand the complexity of the problems and that leadership from all sectors MUST act to make changes to a broken system.
Taxpayer-funded research is not being advanced to market. The TMAF discussions presented in the videos address what we can do to make changes in the system, catalyze an industry, create jobs, and, most importantly, provide cures for patients.
Geoffrey Moore is a best-selling author and venture partner at MDV. Recognized for his expertise in market development and business and investment strategies, he serves as an advisor to many of MDV's portfolio companies,
drawing upon best practices derived from his extensive work with technology startups. Geoffrey has made the understanding and effective exploitation of disruptive technologies the core of his life's work. His books, Crossing the Chasm,
Inside the Tornado, The Gorilla Game, and Living on the Fault Line are best sellers and required reading at leading business schools. Highly regarded as a dynamic public speaker, Geoffrey is the founder of The Chasm Group and currently is
managing director of TCG Advisors. Earlier in his career, he was a principal and partner at Regis McKenna, Inc., a leading high tech marketing strategy and communications company, and for the decade prior, a sales and marketing executive
in the software industry. He holds a bachelor's degree in literature from Stanford University and a doctorate in literature from the University of Washington.
David Neeleman is Chairman and CEO of JetBlue Airways Corporation. JetBlue, which began operations in 2000, serves 23 U.S. cities with 57 new Airbus A320 aircraft. JetBlue is Neeleman's third successful launch in the
aviation business, His goal is to bring people back to air travel by offering low fares, friendly service and a high quality product. JetBlue was rated "Best Domestic Airline" at Conde Nast Traveler's 2003 Readers' Choice Awards for the
second consecutive year, and was runner-up for "Best Domestic Airline" at Travel & Leisure magazine's 2002 and 2003 World's Best Awards. Neeleman's career in the airline industry began in 1984 when he co-founded Morris Air. As
president of Morris Air, he implemented the industry's first electronic ticketing system and pioneered a home reservationist system that is now the foundation of JetBlue's call center. Neeleman sold Morris Air and took the electronic
ticketing to Open Skies. He sold Open Skies to Hewlett Packard in 1999. During this period, Neeleman acted as a consultant to WestJet Airlines, a successful Canadian low-fare start-up airline.
Thomas Nies has a passion for college and university entrepreneurship programs and demonstrates it by offering his company's employee time, expertise and resources.
Can entrepreneurism be taught? A new Babson College study on what influences startup business owners says it can.
Scientific researchers -- and their ideas -- will benefit from a new National Science Foundation effort to bring innovative ideas to market. The NSF Innovation Corps will fund 100 projects a year.
Making new medical discoveries is the lifeblood of the healthcare startup world. That's why the National Institutes of Health wants to lend a hand with a new training program for tomorrow's research geniuses.
Growing your healthcare business can be done by paying attention to four categories, according to a finance professor's book of advice. Read more about how the categories, or colors, can be used to form a growth strategy.
Want to get connected? Sign up to receive regular news, polls and updates from The Kauffman Foundation.
© 2013 Ewing Marion Kauffman Foundation. All Rights Reserved.